(5-(4-Fluoro-2-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)methyl acetate, 95.0%, 250mg

(2S)-2-(Fmoc-amino)dodecanoic acid, 95%, 5g

2-(TERT-BUTYL)-4-IODOANILINE, 95.0%, 250mg

2-Bromo-3-chlorobenzonitrile, 95.0%, 250mg

6-Nitro-benzo[b]thiophene-2-carboxylic acid methyl ester, 95.0%, 5g

1,8-Dibromonaphthalene, 95.0%, 10g

Plan strain-free PLPOLi 10x/0.25 IOS objective for iScope transmitted polarization, no cover glass correction. Working distance 10 mm

2-Amino-4-cyanopyridine, 97.0%, 10g

4-ethynylcyclohexan-1-amine hydrochloride, 95%, 1g

4-Bromothieno[2,3-c]pyridine-2-carboxylic acid, 95+%, 100mg

2,6-Dichloro-4-fluorobenzaldehyde, 95.0%, 25g

2,5-Dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxylate, 95.0%, 1g

tert-Butyl (6-ethynylpyridin-2-yl)carbamate, 97.0%, 1g